BioSpace News Archive

Drug Development

Novo Nordisk’s Wegovy Sustains Weight Loss for Four Years in Two Studies

Presented at this week’s European Congress on Obesity, the two studies also demonstrate that Novo Nordisk’s Wegovy (semaglutide) provides cardiovascular benefits irrespective of starting weight and the amount of weight lost.

May 14, 2024
·
3 min read
·
Tristan Manalac
Business

AbbVie, Gilgamesh Sign Potential $2B Deal to Develop Neuroplastogens for Psychiatric Disorders

With Monday’s agreement, AbbVie joins the industry’s growing interest in next-generation psychiatric therapies and looks to leverage Gilgamesh Pharmaceuticals’ research platform to discover novel neuroplastogens.

May 14, 2024
·
2 min read
·
Tristan Manalac
Business

Bayer Cuts 1,500 Jobs and Lowers 2024 Earnings Guidance as Q1 Sales Dip

In Tuesday’s first-quarter 2024 financial results, Bayer reported a slight drop in sales amid its sweeping companywide restructuring that resulted in workforce reductions, while lowering its full-year earnings outlook.

May 14, 2024
·
2 min read
·
Tristan Manalac
The Many Ways Biopharma Can Use Artificial Intelligence, Including Generative AI

Applications of the technology range from data collection to drug design to raising the alarm on product safety, but its adoption is also creating some anxiety.

May 14, 2024
·
4 min read
·
Neil Versel
Policy

FDA Rejects Dynavax’s Bid to Expand Use of Hepatitis B Vaccine

Dynavax Technologies announced Tuesday that the FDA issued a Complete Response Letter to the company’s sBLA to include a four-dose regimen of Heplisav-B vaccine for adult hemodialysis patients.

May 14, 2024
·
2 min read
·
Kate Goodwin
Career Advice

Career Coach: How to Message Career Gaps During an Interview

Learn how to discuss career gaps and how to be a great hiring manager and interviewer.

May 14, 2024
·
7 min read
·
Carina Clingman
Drug Development

Cytokinetics’ Phase III Data Sets Up Cardiomyopathy Challenge to BMS

Cytokinetics released data Monday on aficamten, an oral small molecule inhibitor of cardiac myosin, showing it significantly boosted exercise capacity in patients with obstructive hypertrophic cardiomyopathy.

May 14, 2024
·
2 min read
·
Tristan Manalac
Policy

Bayer Layoffs, a Big Alzheimer’s Deal, and ASGCT Wrap

Bayer joined BMS in announcing major overhaul; Takeda drops up to $2 billion for an anti-amyloid drug from AC Immune; and BioSpace reflects on last week’s ASGCT meeting—the good, the bad and the ugly.

May 14, 2024
·
1 min read
·
Greg Slabodkin, Heather McKenzie, Jef Akst
Business

Innate Pharma Reports First Quarter 2024 Business Update and Financial Results

Innate Pharma SA reported its consolidated financial results for the quarter ending March 31, 2024.

May 14, 2024
·
12 min read
Business

Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R&D Committee

Dr. Gallagher, current President of R&D at Syndax Pharmaceuticals and former Chief Medical Officer and Head of Development at AbbVie, brings significant experience of end-to-end development that has resulted in the approval of multiple innovative medicines.

May 14, 2024
·
4 min read